Reversible Inhibition of Human Platelet Activation by Hypothermia In Vivo and In Vitro

Alan D Michelson; Hollace MacGregor; Marc R Barnard; Anita S Kestin; Michael J Rohrer; C Robert Valeri

doi:10.1055/s-0038-1642495

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1994; 71(05): 633-640
DOI: 10.1055/s-0038-1642495

Review Article

Schattauer GmbH Stuttgart

Reversible Inhibition of Human Platelet Activation by Hypothermia In Vivo and In Vitro

Authors

Alan D Michelson

The Department of Pediatrics and Division of Vascular Surgery, University of Massachusetts Medical School Worcester, MA, USA

Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Department of Medicine, The Medical Center of Central Massachusetts, Worcester, MA, USA
Hollace MacGregor

The Department of Pediatrics and Division of Vascular Surgery, University of Massachusetts Medical School Worcester, MA, USA

Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Department of Medicine, The Medical Center of Central Massachusetts, Worcester, MA, USA
Marc R Barnard

The Department of Pediatrics and Division of Vascular Surgery, University of Massachusetts Medical School Worcester, MA, USA

Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Department of Medicine, The Medical Center of Central Massachusetts, Worcester, MA, USA
Anita S Kestin

The Department of Pediatrics and Division of Vascular Surgery, University of Massachusetts Medical School Worcester, MA, USA

Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Department of Medicine, The Medical Center of Central Massachusetts, Worcester, MA, USA
Michael J Rohrer

The Department of Pediatrics and Division of Vascular Surgery, University of Massachusetts Medical School Worcester, MA, USA

Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Department of Medicine, The Medical Center of Central Massachusetts, Worcester, MA, USA
C Robert Valeri

The Department of Pediatrics and Division of Vascular Surgery, University of Massachusetts Medical School Worcester, MA, USA

Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Department of Medicine, The Medical Center of Central Massachusetts, Worcester, MA, USA

Abstract

PDF Download

Summary

A hypothermia-induced hemorrhagic diathesis is associated with cardiopulmonary bypass, major surgery, and multiple trauma, but its pathophysiological basis is not well understood. We examined the hypothesis that hypothermia reversibly inhibits human platelet activation in vitro and in vivo. Platelet activation was studied in normal volunteers by whole blood flow cytometric analysis of modulation of platelet surface GMP-140 and the glycoprotein (GP) Ib-IX complex in: a) shed blood emerging from a standardized in vivo bleeding time wound; b) peripheral blood activated in vitro with either thrombin (in the presence of gly-pro-arg-pro, an inhibitor of fibrin polymerization) or the stable thromboxane (TX) A₂ analogue U46619. Platelets in peripheral whole blood were activated at temperatures between 22° C and 37° C. the forearm skin temperature was maintained at temperatures between 22° C and 37° C prior to and during the bleeding time incision. Platelet aggregation was studied in shed blood by flow cytometry and in peripheral blood by aggregometry. Generation of TXB ₂ (the stable metabolite of TXA ₂) was determined by radioimmunoassay. In vitro, hypothermia inhibited both thrombin- and U46619-induced upregulation of GMP-140, downregulation of the GPIb-IX complex, platelet aggregation, and TXB₂ generation. These inhibitory effects of hypothermia were all completely reversed by rewarming the blood to 37° C. In vivo, platelet activation was inhibited by hypothermia as shown by 5 independent assays of shed blood: upregulation of GMP-140, downregulation of the GPIb-IX complex, platelet aggregate formation, TXB ₂ ggeneration, and the bleeding time. In summary, by a combination of immunologic, biochemical, and functional assays, we demonstrate that hypothermia inhibits human platelet activation in whole blood in vitro and in vivo. Rewarming hypothermic blood completely reverses the activation defect. These results suggest that maintaining normothermia or rewarming a hypothermic bleeding patient may reduce the need for platelet transfusions.

PDF (771 kb)

References

References
1 Michelson AD. Pathomechanism of defective hemostasis during and after extracorporeal circulation: The role of platelets. In: Blood use in cardiac surgery Friedel N, Hetzer R, Royston D. (eds.) Darmstadt; Steinkopff Verlag: 1991: 16-26
2 Harker LA, Malpass TW, Branson HE, Hessel EA, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective a-granule release. Blood 1980; 56: 824-834
3 Khuri SF, Wolfe JA, Josa M, Axford TC, Szymanski I, Assousa S, Ragno G, Patel M, Silverman A, Park M. et al Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104: 94-107
4 Patt A, McCroskey BL, Moore EE. Hypothermia-induced coagulopathies in trauma. Surg Clin North Am 1988; 68: 775-785
5 Ferrara A, MacArthur JD, Wright HK, Modlin IM, McMillen MA. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990; 160: 515-518
6 Van de Bor M, Van Bel F, Lineman R, Ruys JH. Perinatal factors and periventricular-intraventricular hemorrhage in preterm infants. Am J Dis Child 1986; 140: 1125-1130
7 Valeri CR, Cassidy G, Khuri S, Feingold H, Ragno G, Altschule MD. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987; 205: 175-181
8 Valeri CR, MacGregor H, Pompei F, Khuri SF. Acquired abnormalities of platelet function. N Engl J Med 1991; 324: 1670
9 Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1991; 16: 1-20
10 McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16: 73-80
11 Michelson AD. Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-IX complex. Semin Thromb Hemost 1992; 18: 18-27
12 Marcus AJ. Platelet eicosanoid metabolism. In: Hemostasis and thrombosis. Basic principles and clinical practice (2nd ed.) Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds.) Philadelphia; Lippincott: 1987: 676-688
13 Leung L, Nachman R. Molecular mechanisms of platelet aggregation. Annu Rev Med 1986; 37: 179-186
14 Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-886
15 Coller BS, Peerschke El, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110
16 Berndt MC, Du X, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633-640
17 Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA. Purification and preliminary characterization of the glycoprotein lb complex in the human platelet membrane. Eur J Biochem 1985; 151: 637-649
18 Du X, Beutler L, Ruan C, Castaldi PA, Berndt MC. Glycoprotein lb and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-1527
19 Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DY. The immunohistological detection of platelets megakaryocytes and thrombi in routinely processed specimens. Histopathology 1988; 13: 257-267
20 Michelson AD, Ellis PA, Barnard MR, Made GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin ADP or an in vivo wound. Blood 1991; 77: 770-9
21 Rohrer MJ, Kestin AS, Ellis PA, Barnard MR, Rodino L, Breckwoldt WL, Li J-M, Michelson AD. High-dose heparin suppresses platelet alpha granule secretion. J Vase Surg 1992; 15: 1000-1009
22 Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birji-niuk V, Ouimet H, Pasche B, Nelson MJ, Benot SE, Rodino LJ, Barnard MR, Michelson AD. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107-117
23 Rodgers RPC. Bleeding time tables: a tabular summary of pertinent literature. Semin Thromb Hemost 1990; 16: 21-138
24 Babson SR, Babson AL. Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations. Am J Clin Pathol 1978; 70: 406-408
25 Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillman RS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989; 10: 448-455
26 Michelson AD, Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib IX, and Ilb-IIIa complex. Blood 1987; 70: 1673-1678
27 Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-138
28 McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprocine binds only lo activated platelets. J Biol Chem 1984; 259: 9799-804
29 Hsu-Lin S-C, Bemian CL, Furie BC, August D, Furie B. A platelet membrane protein expressed duiing platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 1984; 259: 9121-9126
30 Michelson AD, Adelman B, Barnard MR, Carroll E, Handin RI. Platelet storage results in a redistribution of glycoprotein lb molecules. Evidence for a large intraplatelet pool of glycoprotein lb. J Clin Invest 1988; 81: 1734-1740
31 Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680-1697
32 Rossi EC, Simon TL, Moss GS. (eds.) Principles of transfusion medicine. Williams & Wilkins; Baltimore: 1991
33 Yau TM, Carson S, Weisel RD, Ivanov J, Sun Z, Yu R, Glynn MF, Teasdale SJ. The effect of warm heart surgery on postoperative bleeding. J Thorac Chardiovasc Surg 1992; 103: 1155-1162
34 Boldt J, Knothe C, Zickmann B, Bill S, Dapper F, Hempelmann G. Platelet function in cardiac surgery: influence of temperature and aprotinin. Ann Thorac Surg 1993; 55: 652-658
35 Levine SP. Secreted platelet proteins as markers for pathological disorders. In: Biochemistry of platelets Phillips DR Shuman MA Orlando: Academic Press 1986: 378-115
36 Hansen SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin PPACK. Proc Natl Acad Sci USA 1988; 85: 3184-3188
37 Eidt JF, Allison P, Nobel S, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1989; 84: 18-27